Poietis
Poietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting. Poietis is the result of over 10 years of research conducted at INSERM (France’s National Institute for Health and Medical Research) and the University of Bordeaux. The company was…
Funding snapshot
About
Poietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting. Poietis is the result of over 10 years of research conducted at INSERM (France’s National Institute for Health and Medical Research) and the University of Bordeaux. The company was founded in 2014 and headquartered in Pessac, France. It has raised $9M in series a funding, with backing from Europa, Aquiti Gestion. The company operates in the Life Sciences - Life Sciences Platforms and Tools, High Tech - 3D Printing space. Laser-assisted 3D bioprinting technology.
Business model
3D Printing > Hardware > 3D Printers > Industrial Grade > Industry Based > 3D Bio Printers,
Life Sciences Platforms and Tools > Research Services > Diversified
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.